Key facts
- This page summarizes Robert Keith Warner's Form 4 filing for RxSight, Inc. (RXST).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Aug 2021, 19:14.
Robert Keith Warner - 03 Aug 2021 Form 4 Insider Report for RxSight, Inc. (RXST)
- Reporting relationship
- Director
- Issuer ticker
- RXST
- Reported as of
- 03 Aug 2021
- Net transaction value
- +$700,000
- SEC form
- 4
- Accepted by SEC
- 05 Aug 2021, 19:14:35 UTC
- Next SEC filing
- 01 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shelley Thunen, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert Keith Warner filed Form 4 for RxSight, Inc. (RXST) on 05 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$700,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RXST
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,733
- Change %
- Price
- $0.000000
- Shares after
- 5,733
- Date
- 03 Aug 2021
- Ownership
- Direct
- Footnotes
- F1, F2
RXST
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +7,645
- Change %
- +133%
- Price
- $0.000000
- Shares after
- 13,378
- Date
- 03 Aug 2021
- Ownership
- Direct
- Footnotes
- F1, F3
RXST
transaction
Common Stock
Purchase
- Transaction value
- $700,000
- Shares
- +43,750
- Change %
- +327%
- Price
- $16.00
- Shares after
- 57,128
- Date
- 03 Aug 2021
- Ownership
- See footnote
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.
Footnote F2
Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the date immediately prior to the first annual meeting of stockholders following August 3, 2021.
Footnote F3
Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one third of the RSUs subject to the award shall vest on each annual anniversary of August 3, 2021.
Footnote F4
Shares held by the Cabo Living Trust, for which the Reporting Person serves as trustee.